Enzychem Lifesciences Corporation

    Enzychem Lifesciences Corporation

    KKRX:183490
    990.00
    KRW
    0.00
    (0.00%)
    Enzychem Lifesciences Corporation
    KRX:183490
    (Korea Stock Exchange)

    Recent

    price

    990.00

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    2025
    TTM
    KRW
    494.72
    343.37
    440.23
    504.28
    540.1
    516.27
    418.48
    460.48
    - -
    896.84
    945.06
    874.37
    862.06
    Revenue per Share
    -647.76
    -258.73
    -127.65
    -109.34
    -250.96
    -276.91
    -283.76
    -558.47
    - -
    -110
    -270
    -234
    -224.84
    Basic EPS, GAAP
    -61.02
    -119.68
    -253.81
    -150.1
    -299.44
    -294.27
    -277.45
    -490.46
    - -
    -148.14
    -12.98
    -152.18
    -246.99
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    106.38
    454.8
    526.31
    473.39
    1,002.54
    1,238.28
    1,157.43
    1,489.8
    2,390.31
    2,274.9
    2,014
    1,837.07
    1,721.68
    Book Value per Share
    39.21
    421.69
    505.14
    461.34
    993.77
    1,211.94
    1,125.97
    1,360.38
    2,364.38
    2,206.12
    1,948.64
    1,785.29
    1,555.58
    Tangible Book Value per Share
    31
    46
    50
    52
    57
    61
    62
    50
    - -
    85
    82
    77
    80
    Basic Weighted Avg Shares
    15,368
    15,636
    21,835
    26,133
    31,034
    31,469
    25,818
    22,975
    26,638
    76,039
    77,378
    67,751
    69,002
    Sales/Revenue/Turnover
    -15.09
    -44.03
    -28.52
    -20.59
    -46.17
    -57.17
    -69.06
    -90.33
    -55.04
    -18.88
    -25.77
    -19.32
    -20.78
    Operating Margin (%)
    1,497
    1,600
    1,341
    1,579
    1,533
    1,947
    2,036
    2,111
    2,389
    3,512
    3,458
    3,136
    2,590
    Depreciation Expense
    -20,121
    -11,782
    -6,332
    -5,666
    -14,420
    -16,879
    -17,507
    -27,865
    -25,093
    -9,326
    -22,107
    -18,132
    -17,997
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    -130.93
    -75.35
    -29
    -21.68
    -46.47
    -53.64
    -67.81
    -121.28
    -94.2
    -12.27
    -28.57
    -26.76
    -26.08
    Profit Margin (%)
    4,916
    14,953
    19,305
    14,653
    43,783
    55,737
    95,215
    56,163
    178,028
    160,321
    136,855
    107,542
    125,762
    Working Capital
    3,100
    2,100
    2,700
    1,300
    300
    298
    37,437
    3,355
    1,192
    1,609
    345
    1,088
    8,015
    LT Debt
    4,405
    22,420
    26,958
    24,562
    58,817
    74,041
    72,483
    74,662
    201,744
    194,627
    161,483
    138,767
    148,662
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    -88.86
    -25.65
    -22
    -34.59
    -25.44
    -23.93
    -37.93
    -18.19
    -4.72
    -12.49
    -12.17
    -12.04
    Return on Common Equity (%)

    Capital Structure

    KRW

    •

    in mil. unless spec.
    Dec'25
    Mar'26
    Jun'26
    ST Debt
    3,751
    4,928
    3,763
    LT Borrowings
    914
    606
    7,827
    LT Finance Leases
    174
    168
    188
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    75
    85
    85
    Market Capitalization
    114,550
    83,794
    83,794

    Working Capital

    KRW

    •

    in mil. unless spec.
    Dec'25
    Mar'26
    Jun'26
    Total Current Assets
    115,774
    128,850
    136,142
    Cash, Cash Equivalents & STI
    92,821
    104,007
    93,874
    Accounts Receivable, Net
    3,924
    4,428
    5,967
    Inventories
    11,879
    10,647
    22,013
    Total Current Liabilities
    8,232
    9,464
    10,379
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    3,751
    4,928
    3,763
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    KRW

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    31.32%
    27.72%
    -14.07%
    Free Cash Flow
    112.17%
    181.61%
    1,009.13%
    Net Income, GAAP
    22.39%
    21.09%
    -17.98%
    Sales/Revenue/Turnover
    24.12%
    35.94%
    -12.44%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    KRW

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    22,244
    19,605
    17,012
    18,516
    77,378
    2025
    20,783
    16,401
    16,471
    14,096
    67,751
    2026
    14,892
    23,543
    - -
    - -
    - -

    Quarterly Earnings Per Share

    KRW

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    -13
    -40
    -20
    - -
    -270
    2025
    -24
    -39
    -42.68
    - -
    -234
    2026
    -23.53
    -35
    - -
    - -
    - -

    Quarterly Dividends Per Share

    KRW

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business